XCL2 and myeloid sarcoma: Previous microarray studies of MS patient T cells indicated that IVIg upregulated the expression of six immune-related mRNAs (xcl2, kir2ds1, map4k2, ptger4, casp2, and il11) that included IL-11 [25].